NuCana plc ROE Ratio 2011-2026 | NCNA

Annual ROE Ratio NuCana plc

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-30.92	-33.71	-16.96	-24.71	-	-	-	-	-	-

All numbers in GBP currency

Indicator range from annual reports

Maximum	Minimum	Average
-16.96	-33.71	-26.58

Quarterly ROE Ratio NuCana plc

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-10.38	-20.77	-31.56	-31.85	-39.46	-36.69	-36.51	-24.78	-30.31	-28.22	-23.73	-18.63	-21.6	-19.04	-14.44	-11.8	-85.39	-156.02	-167.35	-86.45	-86.45	-12.85	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in GBP currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-10.38	-167.35	-45.19

ROE Ratio of other stocks in the Biotechnology industry

Issuer	ROE Ratio	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	160.08	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	-185.15	-	-	$ 86.2 M	USA
MorphoSys AG MOR	15.76	-	2.43 %	$ 254 M	Germany
Alterity Therapeutics Limited ATHE	-36.22	$ 3.85	3.24 %	$ 9.26 B	Australia
Akouos AKUS	-37.09	-	0.23 %	$ 488 M	USA
Alnylam Pharmaceuticals ALNY	39.76	$ 322.18	-3.36 %	$ 42.2 B	USA
Applied Molecular Transport AMTI	-207.64	-	-	$ 10.1 M	USA
I-Mab IMAB	-85.31	-	-	$ 866 M	China
AlloVir ALVR	-55.11	-	4.14 %	$ 49.1 M	USA
Burford Capital Limited BUR	10.1	$ 4.71	-0.53 %	$ 766 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	5.18	-	-	$ 40.3 B	USA
Cabaletta Bio CABA	-149.8	$ 3.51	3.09 %	$ 353 M	USA
Genfit SA GNFT	626.29	-	2.54 %	$ 160 B	France
Biophytis SA BPTS	-751.94	-	-13.47 %	$ 169 M	France
Aligos Therapeutics ALGS	-45.18	$ 7.72	4.04 %	$ 76.3 M	USA
Allakos ALLK	-110.0	-	-	$ 28.6 M	USA
Ayala Pharmaceuticals AYLA	3458.87	-	-	$ 7.46 M	Israel
EyeGate Pharmaceuticals, Inc. EYEG	-115.61	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	-330.29	-	-18.52 %	$ 27.3 M	Britain
Applied Therapeutics APLT	698.49	-	-	$ 8.42 M	USA
Aptinyx APTX	-169.38	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	-716.17	-	-13.39 %	$ 1.45 M	USA
Brainstorm Cell Therapeutics BCLI	103.22	-	-2.5 %	$ 5.88 M	USA
Amphastar Pharmaceuticals AMPH	12.44	$ 22.0	1.48 %	$ 1.03 B	USA
CymaBay Therapeutics CBAY	-36.05	-	-	$ 3.45 B	USA
BioNTech SE BNTX	1.11	$ 101.75	2.29 %	$ 27.2 B	Germany
Институт стволовых клеток человека ISKJ	17.55	-	-	-	Russia
Advaxis ADXS	196.88	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	-401.79	-	5.93 %	$ 314 M	Canada
Can-Fite BioPharma Ltd. CANF	-175.75	$ 3.07	-3.15 %	$ 5.05 M	Israel
AgeX Therapeutics AGE	51843.24	-	-10.17 %	$ 12.2 K	USA
Galectin Therapeutics GALT	24.11	$ 2.25	-12.11 %	$ 144 M	USA
ContraFect Corporation CFRX	549.72	-	-5.16 %	$ 5.39 M	USA
Aeglea BioTherapeutics AGLE	-21.7	-	-	$ 1.01 B	USA
Akebia Therapeutics AKBA	-16.39	$ 1.38	-10.97 %	$ 355 M	USA
Applied Genetic Technologies Corporation AGTC	-62.37	-	-	$ 26.5 M	USA
Grifols, S.A. GRFS	9.2	$ 8.6	-1.04 %	$ 6.83 B	Spain
Aquestive Therapeutics AQST	248.9	$ 4.28	0.94 %	$ 458 M	USA
Arcutis Biotherapeutics ARQT	-8.52	$ 23.69	-3.64 %	$ 3.01 B	USA
AIkido Pharma AIKI	-32.34	-	1.93 %	$ 17.4 M	USA
BioDelivery Sciences International BDSI	45.18	-	-4.8 %	$ 255 M	USA
Autolus Therapeutics plc AUTL	-161.42	$ 1.59	6.71 %	$ 423 M	Britain
Aptose Biosciences APTO	93.75	-	-45.71 %	$ 1.2 M	Canada
BeiGene, Ltd. BGNE	6.58	-	0.49 %	$ 251 B	Cayman-islands
Checkpoint Therapeutics CKPT	445.47	-	-	$ 169 M	USA
Immatics N.V. IMTX	1.79	$ 10.8	-1.86 %	$ 679 M	Germany
Caladrius Biosciences CLBS	-67.58	-	-16.75 %	$ 25.8 M	USA
AVROBIO AVRO	12.83	-	1083.1 %	$ 745 M	USA
Clearside Biomedical CLSD	204.15	-	-	$ 25.3 M	USA
Celldex Therapeutics CLDX	-49.08	$ 33.63	-0.72 %	$ 2.23 B	USA